期刊文献+

Secretion expression of recombinant glucagon in Escherichia coli 被引量:1

Secretion expression of recombinant glucagon in Escherichia coli
原文传递
导出
摘要 A novel approach for the preparation of recombinant human glucagon was described. An expression vector pAGluT, containing phoA promoter, phoA signal peptide and glucagon gene, was constructed by means of genetic engineering. Escherichia coli strain YK537 was transformed with pAGluT. High-level secretory expression of recombinant human glucagon was achieved. The expression yield of recombinant human glucagon was found to be 80 mg/L, approximately 30% of the total proteins in supernatant. The biological activities and the physicochemical properties of the purified recombinant human glucagon were found to be the same as that of native glucagon. In addition, our results suggested that phoA expression system may be suitable for the expression of other small peptides. A novel approach for the preparation of recombinant human glucagon was described. An expression vector pAGluT, containing phoA promoter, phoA signal peptide and glucagon gene, was constructed by means of genetic engineering. Escherichia coli strain YK537 was transformed with pAGluT. High-level secretory expression of recombinant human glucagon was achieved. The expression yield of recombinant human glucagon was found to be 80 mg/L, approximately 30% of the total proteins in supernatant. The biological activities and the physicochemical properties of the purified recombinant human glucagon were found to be the same as that of native glucagon. In addition, our results suggested that phoA expression system may be suitable for the expression of other small peptides.
出处 《Science China(Life Sciences)》 SCIE CAS 2001年第3期233-240,共8页 中国科学(生命科学英文版)
关键词 GLUCAGON phoA expression system secretion. glucagon, phoA expression system, secretion.
  • 相关文献

参考文献10

  • 1Unson C G,Gurzenda E M,Iwasa K,et al.Glucagon antagonists: Contribution to binding and activity of the amino-terminal sequence1-5, position 12, and the putative ?-helical segment 19-27[].Journal of Biological Chemistry.1989
  • 2Ishizaki J,Tamaki M,Shin M,et al.Production of recombinant human glucagon in the form of a fusion protein in Escherichia coli: recovery of glucagon by sequence-specific digestion[].Applied Microbiology and Biotechnology.1992
  • 3Kim D Y,Shin N K,Chang S G,et al.Production of recombinant human glucagon in Escherichia coli by a novel fusion protein approach[].Biotechnology Techniques.1996
  • 4Shin C S,Hong M S,Kim D Y,et al.Growth-associated synthesis of recombinant human glucagon and human growth hormone in high-cell-density cultures of Escherichia coli[].Applied Microbiology and Biotechnology.1998
  • 5Hall-Boyer K,Zaloga G P,Chernow B.Glucagon: hormone or therapeutic agent[].Critical Care Medicine.1984
  • 6Unger R H.Role of glucagon in the pathogenesis of diabetes: the status of the controversy[].Metabolism.1978
  • 7Unger R H,Orci L.The essential role of glucagon in the pathogenesis of diabetes mellitus[].The Lancet.1975
  • 8Unson C G,Merrifield R B.Identification of an essential serine residue in glucagon: Implication for an active site triad[].Proceedings of the National Academy of Sciences of the United States of America.1994
  • 9Unson C G,Wu C R,Fitzpatrick K J,et al.Multiple-site replacement analogs of glucagon.A molecular basis for antagonist design[].Journal of Biological Chemistry.1994
  • 10Azizeh B Y,Ahn J M,Caspari R,et al.The role of phenylalanine at position 6 in glucagon’s mechanism of biological action: Multiple replacement analogues of glucagon[].Journal of Medicinal Chemistry.1997

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部